♟️ Tuesday 9 September 2025 Tue, 9 Sept 2025

OpenLearning Limited has agreed to convert $1 million of debt owed to its largest shareholder into equity at a premium, significantly increasing that shareholder's stake and reshaping the company's capital structure.

NSX Limited shareholders will decide on a recommended acquisition scheme offering $0.04 cash per fully paid share, representing a substantial premium. The Board and an independent expert endorse the deal, which would see NSX delisted and become a CNSX subsidiary.

CZR Resources has completed the sale of its Robe Mesa Iron Ore Project, netting over A$70 million and wiping out its debt. The company is now poised to accelerate exploration across its remaining Western Australian assets.

Nova Minerals has made a strategic A$1 million investment in Adelong Gold, securing a 9.4% stake and board representation, while maintaining focus on its flagship Estelle Project in Alaska.

Adelong Gold has locked in a $1.25 million strategic investment from Nova Minerals and Barclay Wells clients, enabling accelerated exploration at its NSW and Victorian gold and antimony projects. This partnership includes board representation and offtake rights, positioning Adelong for growth in proven mineral corridors.

Adelong Gold has locked in a $1.25 million strategic investment from Nova Minerals and Barclay Wells clients, enabling accelerated exploration at its NSW and Victorian gold-antimony projects.

Talga Group has signed a strategic cooperation agreement with United Catalyst Corporation, marking its entry into the US battery anode market and setting the stage for new graphite recycling and anode production facilities in South Carolina.

Sunrise Energy Metals has nearly doubled the scandium content at its Syerston Project, confirming it as the world’s largest and highest-grade scandium deposit. This comes as global supply tightens due to new Chinese export restrictions.

Cobram Estate Olives has secured $175 million through an institutional placement to accelerate its expansion in the US, aiming to increase its Californian olive groves to 3,600 hectares and boost olive oil production significantly by 2027.

Adrad Holdings announces immediate board reshuffle with Chairman Glenn Davis stepping down, CEO Paul Proctor promoted to Managing Director, and Donald McGurk appointed Chairman.

Investigator Resources has revamped its Definitive Feasibility Study for the Paris Silver Project, leveraging higher silver prices and secured water to fast-track production. The company also advances exploration and streamlines its portfolio to sharpen focus on precious metals growth.

Brightstar Resources Limited has consolidated its position as a leading Western Australian gold developer through the strategic acquisition of Aurumin Ltd, expanding its resource base and setting ambitious production targets. The company aims to ramp up production from current levels to 200,000 ounces annually by 2029, backed by robust feasibility studies and a multi-hub development strategy.

Snow Lake Energy has completed its strategic investment in American Uranium Limited, acquiring a 9.9% stake and board representation, strengthening ties between adjacent uranium projects in Wyoming amid a U.S. nuclear energy resurgence.

Jindalee Lithium has signed a non-binding LOI to merge its US lithium assets with a US SPAC, aiming to list on a national exchange and unlock significant funding for its McDermitt Project.

Proteomics International Laboratories announces the planned retirement of its founder and Managing Director, Dr Richard Lipscombe, in February 2026, marking a pivotal leadership transition as the company seeks a new CEO to drive its next growth phase.

Euro Manganese Inc. reports significant progress on its Chvaletice Project and Bécancour Plant, positioning itself as a key Western supplier of high-purity manganese critical for EV batteries. The company highlights strong feasibility results, strategic financing partnerships, and multiple offtake agreements amid an expected global supply deficit.

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.

News Corporation’s Murdoch Family Trust is selling 14.2 million Class B shares in a significant secondary offering, marking a pivotal step in a broader ownership restructuring that reshapes voting control and family interests.

News Corporation has settled longstanding legal disputes involving the Murdoch Family Trust, restructuring beneficiary holdings and consolidating voting control under Lachlan Murdoch.